Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hyaluronic Acid,Dextranomer
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Palette Life Sciences Receives Favorable Post Approval Study Results for Solesta
Details : The prospective, single-arm study followed a population of 283 patients and determined that Solesta provided clinically significant, sustained improvement in symptoms and quality of life, without the occurrence of any serious adverse events.
Product Name : Solesta
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 29, 2022
Lead Product(s) : Hyaluronic Acid,Dextranomer
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Oncology
Study Phase : Approved FDF
Sponsor : Silicon Valley Bank
Deal Size : Undisclosed
Deal Type : Financing
Palette Life Sciences Secures Loan Facility for Up to $40 Million with Silicon Valley Bank
Details : The non-dilutive capital provides financial support for commercial and product development including Barrigel, is made from NASHA. Barrigel is an injectable biodegradable material that separates prostate from rectum to protect it during radiation therapy...
Product Name : Barrigel
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
October 28, 2021
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Sponsor : Silicon Valley Bank
Deal Size : Undisclosed
Deal Type : Financing
Reset All
